Mar 28 |
Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company Update
|
Mar 28 |
Earnings Scheduled For March 28, 2024
|
Mar 27 |
Dare Bioscience FY 2023 Earnings Preview
|
Mar 21 |
Daré Bioscience to Host Full Year 2023 Financial Results and Company Update Conference Call and Webcast on March 28, 2024
|
Feb 22 |
Daré Bioscience to Present at the International Society for the Study of Women’s Sexual Health (ISSWSH) Annual Meeting
|
Jan 31 |
Daré Bioscience Announces Positive End-of-Phase 2 Meeting with FDA on Development of Sildenafil Cream, 3.6% in Female Sexual Arousal Disorder and Provides Company Focus Areas for 2024
|
Jan 29 |
Daré Bioscience announces executive team changes
|
Jan 26 |
Daré Bioscience to eliminate CFO and CCO roles to rein in costs
|
Jan 26 |
Daré Bioscience Announces Executive Team and Board of Directors Changes
|
Jan 17 |
Daré Bioscience Announces Grant to Support Biotherapeutic Product Development
|